Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (7)
  • 2024 (5)
  • 2023 (7)
  • 2022 (6)
  • 2021 (4)

Subject

  • Drug Trafficking (355)
  • Synthetic drugs (314)
  • Fake Pills (219)
  • Guns/Weapons (91)
  • Seizures (Drugs/Property) (91)
  • OCDETF/Task Force (65)
  • Guilty Plea (41)
  • Take Back Day (26)
  • Diversion Division (25)
  • Overdose (14)
  • HIDTA (13)
  • Arrests/Convictions - Major (12)
  • Outreach/Drug Prevention (11)
  • Gangs (10)
  • Money Laundering (10)
  • Fentanyl Free America (9)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • Counterfeit Pills (8)
  • Major Law Enforcement Operation (7)
  • One Pill Can Kill (5)
  • Press Conferences (5)
  • Extraditions (3)
  • Dark Web- Internet Trafficking (2)
  • Asset Forfeiture (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Task Forces/Task Force Officers (1)
  • Prescription Drugs (26)
  • Fentanyl Awareness (8)

Drug Name

  • Fentanyl (11)
  • Opioids (6)
  • Hydromorphone (5)
  • Benzodiazepines (3)
  • Oxycodone (3)
  • Methadone (2)
  • Methamphetamine (2)
  • Amphetamines (1)
  • Cocaine (1)
  • Heroin (1)
  • Ketamine (1)
  • Steroids (1)

Field Division

  • Atlanta (25)
  • Chicago (17)
  • Dallas (15)
  • Detroit (3)
  • El Paso (18)
  • Houston (43)
  • Los Angeles (22)
  • Louisville (29)
  • Miami (25)
  • New England (26)
  • New Jersey (18)
  • New Orleans (15)
  • New York (43)
  • Omaha (36)
  • Philadelphia (1)
  • Phoenix (11)
  • Rocky Mountain (19)
  • San Diego (7)
  • San Francisco (18)
  • Seattle (34)
  • Sede (32)
  • St. Louis (49)
  • Washington, DC (52)
Clear All Results
34 Results - Showing 1 to 10
PRESS RELEASE

DEA Seattle Field Division Recognizes National Fentanyl Awareness Day

SEATTLE – For a fifth straight year, the U.S. Drug Enforcement Administration will show its support for “Song for Charlie” and our many valued partners in law enforcement, public health, and non-profit agencies in recognizing National Fentanyl Awareness Day on Wednesday, April 29, 2026. Six months ago, DEA intensified its...
PRESS RELEASE

DEA Hosts the 30th National Prescription Drug Take Back Day on Saturday, April 25th

SEATTLE– The U.S. Drug Enforcement Administration will host the 30th National Prescription Drug Take Back Day on Saturday, April 25, 2026, from 10 a.m. to 2 p.m. at nearly 4,200 locations nationwide. Twice a year, DEA joins forces with local law enforcement and community groups to host DEA’s National Prescription...
PRESS RELEASE

DEA Delivers Major Blows to Drug Cartels, Advancing a Fentanyl Free America in 2026

SEATTLE – Marking a powerful start to 2026, the U.S. Drug Enforcement Administration dealt a significant blow to drug trafficking networks during Phase II of Operation Fentanyl Free America. Between January 12 and February 10, 2026, DEA seized more than 4.7 million fentanyl pills and nearly 2,396 pounds of fentanyl...
PRESS RELEASE

Former Anesthesiology Resident Who Worked at Seattle Children's, UW Medicine, and Harborview Medical Center, Sentenced for Stealing and Using Narcotic Pain Medicine While on Duty

SEATTLE – A 36-year-old former anesthesiology resident at Seattle Children’s Hospital and Harborview and University of Washington Medical Centers was sentenced today in U.S. District Court in Seattle to one year of supervised release including 200 hours of community service for diverting narcotic pain medication to his own use while...
PRESS RELEASE

Portland Veterinarian Sentenced for Diverting Controlled Substances for Personal Use

PORTLAND, Ore. — Dr. Brenda Brown-Carlson, a Portland veterinarian, was sentenced to 60 months of supervised probation on January 13, 2026, in Multnomah County Circuit Court as part of a plea agreement. Brown-Carlson admitted to diverting controlled substances for her personal use and replacing them with saline, impacting the treatment...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

SEATTLE– The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to protecting...
PRESS RELEASE

Former Ellensburg Doctor Indicted on 26 Felony Counts for Falsifying and Issuing Commercial Driver’s Licenses and Prescriptions for Controlled Substances

YAKIMA, Wash. – On November 14, 2025, a federal grand jury for the Eastern District of Washington returned an Indictment charging Anna Elperin, age 42, with 26 felony counts relating to prescriptions for controlled substances and Department of Transportation commercial driver’s licenses physical examinations Elperin wrote and performed at her...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

SEATTLE –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...
PRESS RELEASE

Warning: Thousands of Counterfeit M30 Pills Containing Carfentanil Seized in Western Washington

SEATTLE- The Drug Enforcement Administration Seattle Field Division is warning the public after a seizure of counterfeit M30 pills containing carfentanil in Western Washington. On Tuesday, September 16th, 2025, after a months-long investigation, the Drug Enforcement Administration (DEA), Alcohol Tobacco and Firearms (ATF), Federal Way Police and Centralia Police seized...
PRESS RELEASE

UW Medicine Resident Physician at Seattle Children’s Hospital Charged for Diverting Fentanyl

SEATTLE, Wash.--Dr. Andrew Voegel-Podadera, 35, a resident physician at the University of Washington Medical School who worked at Seattle Children’s Hospital, UW Medicine, and Harborview Medical Center is charged with two counts of Acquiring a Controlled Substance by Misrepresentation, Fraud, Deception, and Subterfuge. On June 24th, 2025, DEA Seattle Diversion...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster